Next-Generation Sequencing (NGS) services are the dominating segment. Their leadership is driven by the increasing demand for fast, accurate, and affordable sequencing solutions used in genomics research, personalized medicine, and infectious disease monitoring.
Key growth drivers include the rising demand for precision medicine, the intensification of omics studies (genomics, proteomics, and metabolomics), the integration of AI and machine learning for data interpretation, and increased government and private funding for biomedical research.
AI is revolutionizing the industry by enabling faster and more precise interpretation of massive datasets. Recent developments include AI-assisted genomic interpretation tools to reduce processing time and AI-integrated proteomics workflows that expedite biomarker identification for oncology and rare diseases.
North America dominates the market, accounting for nearly half of the total revenues in 2024. This dominance is attributed to a highly developed biotechnology ecosystem, substantial funding from institutions like the NIH, and advanced clinical research infrastructure in the United States and Canada.
The Asia-Pacific region is the fastest-growing market, projected to expand at a double-digit CAGR. Growth is fueled by large-scale genomics programs in China, cost-effective research capabilities in India, and significant investments in regenerative medicine in Japan.
Biological data curation is a critical segment that ensures the accuracy, standardization, and reproducibility of omics research. It involves structured annotation and metadata integration, which are essential for pharmaceutical companies and healthcare providers to meet regulatory compliance and perform reliable predictive modeling.
The industry faces several hurdles, including concerns over data security and privacy in cloud-based platforms, a global shortage of skilled bioinformatics professionals, the high cost of advanced computational infrastructure, and the complexity of integrating heterogeneous multi-omics datasets.
The shift toward integrated, cloud-native platforms has brought essential scalability, security, and interoperability to the market. These platforms serve as the backbone for international research consortia, allowing for real-time data sharing and harmonized pipelines across borders.
The market features prominent leaders including Illumina Inc., Thermo Fisher Scientific, BGI Group, Qiagen N.V., Eurofins Scientific, Genewiz (Azenta Life Sciences), PerkinElmer Inc., DNAnexus, Seven Bridges Genomics, and Biomax Informatics AG.
